SCHEMBL20019548

SCHEMBL20019548

CCCCCC[C@@H](O)[C@@H](O)[C@H](COC1OC(COCc2ccccc2)C(OCc2ccccc2)C(OCc2ccccc2)C1OCc1ccccc1)NC(C)=O

nearest known ligand 0.51

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ SELP P16109 3/20 0.51
▸ PTPN1 P18031 11/20 0.47
▸ CDC25B P30305 9/20 0.47
▸ PTPN2 P17706 6/20 0.44
▸ PTPN11 Q06124 6/20 0.44
▸ PTPN6 P29350 5/20 0.44
▸ TACR1 P25103 1/20 0.44
▸ NT5E P21589 1/20 0.44
▸ SSTR1 P30872 1/20 0.43
▸ SSTR2 P30874 1/20 0.43
▸ SSTR4 P31391 1/20 0.43
▸ SSTR3 P32745 1/20 0.43
▸ SSTR5 P35346 1/20 0.43
▸ CDC25A P30304 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12202043 0.90 SELP (0.52) SELPPTPN1CDC25BPTPN2PTPN11
SCHEMBL12202044 0.88 SELP (0.54) SELPPTPN1CDC25BPTPN2PTPN11
SCHEMBL12202054 0.88 SELP (0.45) SELPPTPN1CDC25BPTPN2PTPN11
SCHEMBL12202036 0.88 SELP (0.45) SELPPTPN1CDC25BPTPN2PTPN11
SCHEMBL12202025 0.87 PTPN1 (0.45) SELPPTPN1CDC25BPTPN2PTPN11
SCHEMBL12202028 0.87 PTPN1 (0.45) SELPPTPN1CDC25BPTPN2PTPN11
SCHEMBL20019579 0.87 SELP (0.59) SELPPTPN1CDC25BPTPN2PTPN11
SCHEMBL2605165 0.87 SELP (0.47) SELPPTPN1CDC25BPTPN2PTPN11
SCHEMBL12202053 0.86 SELP (0.49) SELPPTPN1CDC25BPTPN2PTPN11
SCHEMBL12202058 0.86 SELP (0.52) SELPPTPN1CDC25BPTPN2PTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2343306-B1 Glycolipid derivatives, process for production of the same, intermediates for synthesis thereof, and process for production of the intermediates JAPAN PRESIDENT NAT CT NEUROLOGY & PSYCHIATRY (JP) 2018-04-04 — — EP disclosed
Send feedback